How to buy Bioventix shares

Bioventix (BVXP) is a publicly traded biotechnology business based in the UK which employs around 0 staff. Bioventix is listed on the London Stock Exchange (LSE) and traded in sterling. Its current price of 4325p is 3.9% down on its price a month ago (4500p).

Our top picks for where to buy Bioventix shares

Best for 0% commission stocks

Finder Award

Go to site

Capital at risk. Other fees apply.

Copy picks from top traders

• Commission-free stock trades
• Receive dividend payments
• Invest in fractional shares

Best for fractional shares

Go to site

Capital at risk. T&Cs apply.

Personalised market updates

• Commission-free trading
• Invest in fractional shares
• Over 5,400 stocks & ETFs

Best for customer satisfaction

Finder Award

Go to site

Capital at risk. T&Cs apply.

97% would recommend

• No commissions for funds
• Expert research and insights
• Wide range of tax wrappers

Fees calculator for buying Bioventix shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

Platform	Finder score	Account fee	Min. initial deposit	Trade cost	Link
	4.39 ★★★★★	£0	$100	£873.67	Go to siteCapital at risk
	3.75 ★★★★★	0.12% per year	£0	£870.93	Go to siteCapital at risk
	4.3 ★★★★★	£0	£0	£869.33	Go to siteCapital at risk
	4.4 ★★★★★	£0	£0	£869.33	Go to siteCapital at risk
	4.2 ★★★★★	£0	£1	£881.28	Go to siteCapital at risk
	4.34 ★★★★★	0% - 0.25%	£100	£869.33	Go to siteCapital at risk
	4.1 ★★★★★	£0	£0	N/A	Read reviewCapital at risk

Full comparison of share dealing platforms

Alternative ways to invest in Bioventix

• Via a fund

Is it a good time to buy Bioventix stock?

Only you can make the decision on the time to leap... but here's some supporting information and analysis.

• Price graph
• Historical data
• Technical analysis

Invest in Bioventix shares

Finder Award

• Start investing from $50
• Pay no stamp duty on UK shares
• Commission-free trading. Other fees may apply.

Go to site

Capital at risk

Other fees may apply

Is Bioventix under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Bioventix P/E ratio, PEG ratio and EBITDA

• P/E ratio
• Bioventix EBITDA

Frequently asked questions

• Does Bioventix pay dividends?

  • Dividend yield
  • Forward yield
  • Payout ratio

  Dividend yield: 3.65% of stock value

  Forward annual dividend yield: 3.65% of stock value

  Dividend payout ratio: 93.06% of net profits

  Bioventix has recently paid out dividends equivalent to 3.65% of its share value annually.

  Bioventix has paid out, on average, around 93.06% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 3.65% return on their shares, in the form of dividend payments. In Bioventix's case, that would currently equate to about 158 per share.

  Bioventix's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

  The latest dividend was paid out to all shareholders who bought their shares by 10 April 2024 (the "ex-dividend date").

• What percentage of Bioventix is owned by insiders or institutions?

  Currently 8.078% of Bioventix shares are held by insiders and 62.904% by institutions.

• When does the fiscal year end for Bioventix?

  Bioventix's fiscal year ends in June.

• Where is Bioventix based?

  Bioventix's address is: 7 Romans Business Park, Farnham, United Kingdom, GU9 7SX

• How to sell Bioventix shares

  It's as easy to sell Bioventix as it is to buy! Here's how to sell Bioventix shares that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your Bioventix shares. Your investment platform will let you know when your shares are sold

• Can you buy Bioventix shares with a debit card?

  Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy Bioventix shares?

  The easiest way to get hold of some Bioventix shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Bioventix shares.

• Do you need to complete a W8-BEN form if you want to invest in Bioventix

  If you're investing in a US stock, you'll need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for Bioventix?

  Bioventix financials

  Revenue TTM	£13.6 million
  Operating margin TTM	77.28%
  Gross profit TTM	£11 million
  Return on assets TTM	54.07%
  Return on equity TTM	79.14%
  Profit margin	63.73%
  Book value	2.19p
  Market capitalisation more info button	£225.8 million

  TTM: trailing 12 months

• Can I buy Bioventix shares with eToro?

  No. But you may have more luck with IG, Hargreaves Lansdown or Freetrade, as these platforms have a wider coverage of stocks than eToro.